A carregar...

In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity.

The novel indoloquinone compound EO-9 is shortly to undergo phase I clinical evaluation as a potential bioreductive drug. Preclinical studies have shown that EO-9 has greater activity against cells derived from human solid tumours than leukaemias in vitro. The results of this study extend the precli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Phillips, R. M., Hulbert, P. B., Bibby, M. C., Sleigh, N. R., Double, J. A.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1992
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977599/
https://ncbi.nlm.nih.gov/pubmed/1558788
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!